Due to the discrepancies in the results of the studies outlined (Supplementary Table 1) above, Chen et al. conducted a meta-analysis and reported that an elevated pretreatment CRP level is an indicator of poor prognosis in HNSCC (36). Here, CRP is linked to head and neck squamous cell carcinoma.